-
EP3621658
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3621658
| EP3621658 - PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, USEFUL IN THERAPY, AND THEIR PREPARATION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.02.2020 Database last updated on 12.07.2024 | |
| Former | The international publication has been made Status updated on 16.11.2018 | ||
| Former | unknown Status updated on 19.05.2018 | Most recent event Tooltip | 13.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states SANOFI 46 avenue de la Grande Armée 75017 Paris / FR | [2023/02] |
| Former [2020/12] | For all designated states Sanofi 54 Rue de la Boetie 75008 Paris / FR | Inventor(s) | 01 /
BOUCHARD, Hervé 8 Allée Paul Aster 94230 Thiais / FR | 02 /
BRUN, Marie-Priscille 7 Rue Bargue 75015 Paris / FR | 03 /
HUBERT, Philippe 27 Rue Arthur Dalidet 94700 Maisons-Alfort / FR | [2020/12] | Representative(s) | Cabinet Nony 11 rue Saint-Georges 75009 Paris / FR | [N/P] |
| Former [2020/12] | Nony 11 rue Saint-Georges 75009 Paris / FR | Application number, filing date | 18722557.8 | 09.05.2018 | [2020/12] | WO2018EP61989 | Priority number, date | EP20170305531 | 10.05.2017 Original published format: EP 17305531 | [2020/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018206635 | Date: | 15.11.2018 | Language: | EN | [2018/46] | Type: | A1 Application with search report | No.: | EP3621658 | Date: | 18.03.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.11.2018 takes the place of the publication of the European patent application. | [2020/12] | Search report(s) | International search report - published on: | EP | 15.11.2018 | Classification | IPC: | A61K47/65, C07D273/08, A61K47/68, A61P35/00 | [2020/12] | CPC: |
A61K47/65 (EP,EA,IL,KR,US);
C07D405/06 (EP,EA,IL,KR,US);
A61K38/15 (EP,EA,IL,KR,US);
A61K47/10 (EA,IL,US);
A61K47/22 (EA,IL,US);
A61K47/64 (EA,IL,KR,US);
A61K47/6829 (EP,EA,IL,KR,US);
A61K47/6889 (EP,EA,IL,KR,US);
A61P35/00 (EP,EA,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/12] | Validation states | MA | 06.11.2019 | Title | German: | PEPTIDISCHE LINKER UND CRYPTOPHYCIN-KONJUGATE FÜR DIE THERAPIE UND DEREN HERSTELLUNG | [2020/12] | English: | PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, USEFUL IN THERAPY, AND THEIR PREPARATION | [2020/12] | French: | LINKERS PEPTIDIQUES ET CONJUGUÉS DE CRYPTOPHYCINE, UTILES EN THÉRAPIE, ET LEUR PRÉPARATION | [2020/12] | Entry into regional phase | 06.11.2019 | National basic fee paid | 06.11.2019 | Designation fee(s) paid | 06.11.2019 | Examination fee paid | Examination procedure | 06.11.2019 | Examination requested [2020/12] | 06.11.2019 | Date on which the examining division has become responsible | 26.05.2020 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 31.03.2020 | Renewal fee patent year 03 | 12.05.2021 | Renewal fee patent year 04 | 20.03.2022 | Renewal fee patent year 05 | 14.03.2023 | Renewal fee patent year 06 | 13.03.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDAI]WO2011001052 (SANOFI AVENTIS [FR], et al); | [Y]WO2015057876 (SORRENTO THERAPEUTICS INC [US]); | [X]WO2016172273 (STEM CENTRX INC [US]); | by applicant | WO2005077090 | WO2008010101 | WO2011001052 | WO2011000152 | WO2011039724 | WO2016EP76603 |